Cost of Obamacare expected to soar as subsidies expire and insurers hike premiums

ACA health insurance premiums are projected to sharply increase in 2026, driven primarily by the expiration of enhanced federal subsidies and insurers proposing an average 15% hike, the largest in seven years. This could lead to a significant rise in out-of-pocket costs for millions, with some families seeing monthly premiums more than double, and potentially 4 million people losing coverage. Insurers are also citing concerns over potential drug tariffs and rising healthcare service costs, including GLP-1 drugs, contributing to what analysts view as an effective partial repeal of ACA affordability gains.

Analysis

The Affordable Care Act (ACA) insurance market is poised for a significant disruption in 2026, driven by the dual impact of expiring federal subsidies and substantial proposed premium increases by insurers. According to a KFF analysis of filings from over 100 insurers, the average proposed premium hike is 15%, the largest in seven years, with over a quarter of insurers proposing increases of 20% or more. This is compounded by the non-extension of enhanced subsidies from the American Rescue Plan, which a Congressional Budget Office analysis projects could cause nearly 4 million people to lose coverage. The financial impact on consumers is severe; KFF estimates a family of three earning $110,000 could see monthly premiums jump from $779 to as high as $1,662. Insurers attribute the rate hikes not only to the changing subsidy landscape but also to rising healthcare service costs, the high expense of GLP-1 drugs, and the potential for up to 200% tariffs on imported pharmaceuticals threatened by the Trump administration. This confluence of factors is viewed by policy experts as an 'effective partial repeal of the ACA,' which could reverse recent record enrollment gains and significantly increase financial strain on households.

Key Decisions for Investors

• Investors in health insurers with significant ACA exchange exposure should anticipate heightened volatility, as proposed 15% premium hikes may protect margins but could be offset by a substantial drop in enrollment, projected at nearly 4 million people.
• Hospital operators and healthcare providers face a material risk of rising uncompensated care and bad debt, directly linked to the potential loss of coverage for millions of individuals, which could negatively impact revenues and profitability.
• The explicit mention of potential 200% tariffs on pharmaceuticals introduces a major supply chain and margin risk for drug and medical device manufacturers, warranting a portfolio review for companies with high dependency on overseas production.
• The sharp, projected increase in out-of-pocket healthcare costs for millions of households represents a direct headwind for consumer discretionary spending, a macroeconomic factor to consider for retail and consumer-facing sectors in 2026.